July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Insulin is a vital molecule. ... As much as GLP-1 agonists like Ozempic and Wegovy have gained cultural relevance as weight-loss ... It could be impairing the vessel structure,” she explains.

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

A new monthly weight loss drug, MariTide, helped people shed up to 20% of body weight in a Phase 2 trial—comparable to Wegovy ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists ...

Some potential side effects of Ozempic and other GLP-1 medications, including dry mouth and increased stomach acid, may lead to dental issues like tooth decay, though evidence is anecdotal.